Alexandria Equities Prices $750 Million Senior Notes Offering

Alexandria Equities ( (ARE) ) has provided an announcement.

On February 10, 2026, Alexandria Real Estate Equities, Inc. and its operating partnership entered into an underwriting agreement with a syndicate of major banks for a $750 million issuance of 5.25% senior notes due 2036, which will be fully and unconditionally guaranteed by the partnership. The notes, offered under an existing shelf registration, are expected to be delivered to purchasers around February 25, 2026, adding a new long-dated unsecured debt tranche to the REIT’s capital structure.

Also on February 10, 2026, Alexandria commenced an underwritten public offering of these unsecured senior notes, managed by Citigroup, BofA Securities, J.P. Morgan, Scotia and TD, with proceeds earmarked primarily to repay commercial paper borrowings incurred to fund the repurchase or redemption of certain outstanding senior unsecured notes under a previously announced cash tender offer. This refinancing move is set to extend the company’s debt maturities and reduce reliance on short-term funding, with potential implications for interest costs and balance-sheet flexibility for stakeholders, including bondholders and shareholders.

The most recent analyst rating on (ARE) stock is a Hold with a $54.00 price target. To see the full list of analyst forecasts on Alexandria Equities stock, see the ARE Stock Forecast page.

Spark’s Take on ARE Stock

According to Spark, TipRanks’ AI Analyst, ARE is a Neutral.

The score is held back primarily by weakened financial performance (notably the 2025 earnings reversal) and cautious near-term operating outlook from the earnings call (occupancy/NOI pressure and impairments). Offsetting factors include solid underlying cash generation, constructive near-term technical momentum, and an attractive dividend yield.

To see Spark’s full report on ARE stock, click here.

More about Alexandria Equities

Alexandria Real Estate Equities, Inc., an S&P 500 company, is a mission-driven life science real estate investment trust that pioneered the life science real estate niche after its founding in 1994. The company is the leading long-tenured owner, operator and developer of collaborative Megacampus ecosystems in top-tier life science clusters, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle and New York City.

Its portfolio targets AAA life science innovation markets, positioning Alexandria as a key infrastructure provider to biotech, pharmaceutical and research tenants that rely on specialized lab and office space. This focus underpins its strategy and differentiates it within the broader REIT universe, where it competes on location quality, tenant mix and development capabilities in high-barrier coastal markets.

Average Trading Volume: 2,844,738

Technical Sentiment Signal: Sell

Current Market Cap: $9.85B

For detailed information about ARE stock, go to TipRanks’ Stock Analysis page.